MC

537.9

+1.32%↑

CABK

11.26

-2.34%↓

INGA

25.655

-1.97%↓

NDA.FI

16.72

-1.7%↓

BKT

14.775

-0.81%↓

MC

537.9

+1.32%↑

CABK

11.26

-2.34%↓

INGA

25.655

-1.97%↓

NDA.FI

16.72

-1.7%↓

BKT

14.775

-0.81%↓

MC

537.9

+1.32%↑

CABK

11.26

-2.34%↓

INGA

25.655

-1.97%↓

NDA.FI

16.72

-1.7%↓

BKT

14.775

-0.81%↓

MC

537.9

+1.32%↑

CABK

11.26

-2.34%↓

INGA

25.655

-1.97%↓

NDA.FI

16.72

-1.7%↓

BKT

14.775

-0.81%↓

MC

537.9

+1.32%↑

CABK

11.26

-2.34%↓

INGA

25.655

-1.97%↓

NDA.FI

16.72

-1.7%↓

BKT

14.775

-0.81%↓

Search

Gimv NV

Ouvert

SecteurFinance

44 -1.68

Résumé

Variation du prix de l'action

24h

Actuel

Min

43.9

Max

44.9

Chiffres clés

By Trading Economics

Revenu

127M

Ventes

-49M

65M

P/E

Moyenne du Secteur

7.709

27.185

BPA

3.4

Rendement du dividende

5.71

Marge bénéficiaire

195.239

Employés

94

EBITDA

52M

128M

Dividendes

By Dow Jones

Rendement du dividende

Moyenne du Secteur

5.71%

4.21%

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

53M

1.7B

Ouverture précédente

45.68

Clôture précédente

44

Sentiment de l'Actualité

By Acuity

50%

50%

171 / 445 Classement par Finance

Gimv NV Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

5 févr. 2026, 00:00 UTC

Actions en Tendance

Stocks to Watch: Crown Castle, Qualcomm, Arm, U-Haul

4 févr. 2026, 22:55 UTC

Résultats

Qualcomm 1Q Sales Rise, But Memory Shortage Dents Outlook -- Update

4 févr. 2026, 21:44 UTC

Résultats

Arm Holdings 3Q Profit Falls Despite Revenue Growth

4 févr. 2026, 21:39 UTC

Résultats

Qualcomm 1Q Sales Rise, But Memory Shortage Dents Outlook

5 févr. 2026, 00:00 UTC

Résultats

Renesas Electronics FY Loss Y51.76B Vs Net Y219.08B

5 févr. 2026, 00:00 UTC

Résultats

Renesas Electronics FY Loss Y51.76B Vs Net Y219.08B

4 févr. 2026, 23:46 UTC

Market Talk

Nikkei May Rise as Weaker Yen Supports Earnings Hopes -- Market Talk

4 févr. 2026, 23:45 UTC

Résultats

Google to Double Spending as Earnings Beat Wall Street Expectations -- 4th Update

4 févr. 2026, 23:32 UTC

Market Talk

Gold Rises on Possible Dip-Buying Amid Lingering U.S.-Iran Tensions -- Market Talk

4 févr. 2026, 22:59 UTC

Acquisitions, Fusions, Rachats

SiTime to Buy Timing Business From Renesas Electronics For $1.5B

4 févr. 2026, 22:30 UTC

Résultats

Salesforce Stock Is Battered, and Super Cheap. Hang Tight. -- Barrons.com

4 févr. 2026, 22:30 UTC

Résultats

Alphabet's Cloud Is Shining as CapEx Heads Even Higher -- Barrons.com

4 févr. 2026, 22:21 UTC

Résultats

Snap Stock Pops After Surprise Earnings Beat -- Barrons.com

4 févr. 2026, 22:17 UTC

Market Talk

WiseTech Faces Risks in Both Directions From DSV's Progress -- Market Talk

4 févr. 2026, 22:15 UTC

Market Talk

Santos Should Lay Out Strategic Plans at Annual Result -- Market Talk

4 févr. 2026, 22:00 UTC

Market Talk

ESG Roundup: Market Talk

4 févr. 2026, 21:53 UTC

Résultats

Google to Double Spending as Earnings Beat Wall Street Expectations -- 3rd Update

4 févr. 2026, 21:51 UTC

Résultats

Snap Stock Pops After Surprise Earnings Beat -- Barrons.com

4 févr. 2026, 21:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

4 févr. 2026, 21:50 UTC

Market Talk
Acquisitions, Fusions, Rachats

Financial Services Roundup: Market Talk

4 févr. 2026, 21:50 UTC

Market Talk
Résultats

Auto & Transport Roundup: Market Talk

4 févr. 2026, 21:50 UTC

Market Talk

Health Care Roundup: Market Talk

4 févr. 2026, 21:45 UTC

Résultats

Arm Holdings Reported Record Revenue. The Stock is Falling. -- Barrons.com

4 févr. 2026, 21:44 UTC

Résultats

Qualcomm Gives Weak Guidance. The CEO Blames Memory Crunch. -- Barrons.com

4 févr. 2026, 21:43 UTC

Résultats

Google to Double Spending as Earnings Beat Wall Street Expectations -- 2nd Update

4 févr. 2026, 21:41 UTC

Résultats

These Stocks Are Today's Movers: AMD, AbbVie, Boston Scientific, Eli Lilly, MP Materials, Super Micro, Palantir, and More -- Barrons.com

4 févr. 2026, 21:36 UTC

Market Talk

Latest Canada Green Bond Raises C$2 Billion -- Market Talk

4 févr. 2026, 21:30 UTC

Résultats

Alphabet Reports Solid Earnings. CapEx Heads Even Higher. -- Barrons.com

4 févr. 2026, 21:30 UTC

Résultats

Alphabet Reports Solid Earnings. CapEx Heads Even Higher. -- Barrons.com

4 févr. 2026, 21:30 UTC

Résultats

Beach Energy Interim Dividend 1 Australian Cent/Sjare

Comparaison

Variation de prix

Gimv NV prévision

Note du Consensus

By TipRanks

0 ratings

0

Achat

0

Maintien

0

Vente

Sentiment

By Acuity

171 / 445Classement par Finance

Sentiment de l'Actualité

Neutral

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Inférieur à la moyenne

Éléments financiers

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Gimv NV

Gimv NV is a private equity and venture capital firm specializing in direct and fund of funds investments. For direct investments, the firm specializes in buyouts, growth capital, middle market, debt, shareholder loans, seed, startups, early to mid-stage, late venture, public to private transactions, small and medium sized enterprises, later stage, mature, replacement capital, bridge financing, and recapitalization. Within fund of funds, it seeks to invest in venture capital and private equity funds. It seeks to invest in high performance growth companies that respond to that can speed up their internal growth through acquisitions. The firm typically invests in consumer, connected consumer, fintech; health and care; smart industries; and sustainable cities. Within consumer, it seeks to provide growth capital to emerging leaders. Within health and care platform, the firm seeks to invest in companies that can grow either organically or through a buy and build strategy. Within consumer, it focuses on consumer goods, food and beverage, healthy food, sport, convenience food, personal luxury, career, home & deco, baby & kids, pet products, retail, consumer services, media and content, travel and leisure, education, digital economy and online sectors. Within health and care sector, it focuses on life sciences, medtech, and health and care services. The firm focuses on biotech/biopharma comprising drugs, platform technologies, vaccines and diagnostic tests, preclinical, early clinical, and late clinical, medtech such as medical devices, consumables, IT and small equipment, and health and care services-based companies. It also seeks to be an active shareholder, preferably lead or co-lead in its investments. Within smart industries, it focuses on equipment, services and tools for resource efficient development and production, automotive and aerospace, both optimizing of the existing and development of new means of transport, software and services harnessing the flexibility of the cloud, smart data management and advanced c
help-icon Live chat